Arthritis Research & Therapy

official impact factor 4.36

How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?

Diane L Kamen

Arthritis Research & Therapy 2009, 11:129 doi:10.1186/ar2818


See related research by Ruiz-Irastorza et al., http://arthritis-research.com/content/11/4/R109

Accesses  

  • Last 30 days: 39 accesses
  • Last 365 days: 437 accesses
  • All time: 1993 accesses